Healthier Capital is a premier health-tech venture capital firm dedicated to driving transformative shifts in the healthcare landscape through technology-powered innovation. Based in Menlo Park, the firm was founded on the principle that superior health outcomes and significant value creation are inextricably linked. Healthier Capital distinguishes itself through a team of "been there, done that" operators who have led some of the most influential organizations in modern healthcare. The firm acts as a high-impact strategic partner, leveraging an unparalleled network across health systems, insurers, and policymakers to help early-stage companies navigate the complexities of clinical adoption and regulatory compliance.
In January 2026, Healthier Capital announced the closing of its oversubscribed inaugural fund, Fund 1, at 220 million dollars. The fund reached its cap with support from a prestigious group of limited partners, including leading universities, endowments, family offices, and major healthcare organizations.
Fund 1 is designed to back compelling early-stage innovators where the firm's deep operational expertise can act as a catalyst for growth. The vehicle has already deployed capital into a portfolio of companies recognized for their promise in digital health, focusing on lead and co-lead positions in rounds ranging from Pre-Seed to Series A.
Leadership
The firm is led by CEO and Founding Managing Partner Amir Dan Rubin, the former CEO of Amazon | One Medical and a veteran executive with past leadership roles at Optum, Stanford Health Care, and UCLA Health. He is joined by a team of industry leaders including Gregor Kevrekian, Aman Mahajan MD/PhD, and Eric Epstein. This leadership group brings together a rare combination of experience from McKinsey, CVS Health, Aetna Ventures, and UPMC, providing the firm with a 360-degree view of the healthcare value chain from both the provider and payer perspectives.
Investment Strategy
Healthier Capital employs an operator-led investment strategy that prioritizes business model effectiveness alongside technical innovation. They seek to be the "best-in-class strategic partner" for founders, often entering at the earliest stages to help shape commercial opportunities and governance. The firm’s strategy involves deep board-level engagement and the use of its massive industry network to accelerate the performance of its portfolio. They are particularly adept at identifying "responsible AI" applications that can be deployed across healthcare enterprises in days rather than months, focusing on high-margin, scalable software and service models.
Notable Investments
The firm's portfolio includes transformative health-tech companies such as:
Notable Exits
Healthier Capital has already demonstrated its ability to back winners with the successful acquisition of its portfolio company Ezra, an AI-imaging leader, by Function Health in May 2025.
Other
Healthier Capital is more than just a source of capital; they are specialized builders who understand the "long game" of healthcare. Their co-founding of Diploid Genomics with J. Craig Venter, a pioneer of the human genome project, illustrates their willingness to get involved at the molecular level of company creation. They are an ideal match for founders who need a partner capable of opening doors at the highest levels of the US health system and who can provide the clinical and operational credibility required to win in a highly regulated market.
United States
